ABBOTT IRELAND FINANCING DAC AND ABBOTT LABORATORIES, as PARENT GUARANTOR AND U.S. BANK NATIONAL ASSOCIATION, as TrusteeIndenture • September 28th, 2018 • Abbott Laboratories • Pharmaceutical preparations • New York
INDENTURE, dated as of September 27, 2018 between Abbott Ireland Financing DAC, a designated activity company incorporated under the laws of Ireland (herein called the “Company”), having its registered office at 70 Sir John Rogerson’s Quay Dublin 2, Dublin, D02 R296, Ireland, Abbott Laboratories, a corporation duly organized and existing under the laws of the State of Illinois (herein called the “Parent Guarantor”), having its principal office at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500 and U.S. Bank National Association, a national banking association duly organized and existing under the laws of the United States of America, as Trustee (herein called the “Trustee”).
ABBOTT IRELAND FINANCING DAC SUPPLEMENTAL INDENTURE NO. 1 € 1,140,000,000 0.000% Notes due 2020 € 1,140,000,000 0.875% Notes due 2023 € 1,140,000,000 1.500% Notes due 2026Supplemental Indenture • September 28th, 2018 • Abbott Laboratories • Pharmaceutical preparations • New York
THIS SUPPLEMENTAL INDENTURE NO. 1, dated as of September 27, 2018 (the “Supplemental Indenture”), among ABBOTT IRELAND FINANCING DAC, an Irish designated activity company (the “Company”), ABBOTT LABORATORIES, an Illinois corporation (the “Parent Guarantor”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”), ELAVON FINANCIAL SERVICES DAC, U.K. BRANCH, as paying agent and transfer agent (the “Paying Agent” and/or “Transfer Agent”) and ELAVON FINANCIAL SERVICES DAC, as registrar (the “Security Registrar”).
